Remyelination in neuromyelitis optica spectrum disorder is promoted by edaravone through <scp>mTORC1</scp> signaling activation-Reference-Cited by-同舟云学术

Remyelination in neuromyelitis optica spectrum disorder is promoted by edaravone through mTORC1 signaling activation

Published:2022-09-12 Issue:2 Volume:71 Page:284-304
ISSN:0894-1491
Container-title:Glia
language:en
Short-container-title:Glia

Author:

Luo Wenjing¹,Xu Huiming¹,Xu Li¹,Jiang Wei¹,Chen Chen¹,Chang Yanyu¹,Liu Chunxin¹,Tian Zhenming²,Qiu Xiusheng³,Xie Chichu⁴,Li Xuejia⁵,Chen Haijia⁵,Lai Shuiqing⁶,Wu Longjun⁷^ORCID,Cui Yaxiong⁸,Tang Changyong¹,Qiu Wei¹^ORCID

Affiliation:

1. Department of Neurology The Third Affiliated Hospital of Sun Yat‐Sen University Guangzhou Guangdong Province China

2. Department of Spine Surgery The Third Affiliated Hospital of Sun Yat‐Sen University Guangzhou Guangdong Province China

3. Vaccine Research Institute The Third Affiliated Hospital of Sun Yat‐Sen University Guangzhou Guangdong Province China

4. Department of Clinical Immunology The Third Affiliated Hospital of Sun Yat‐Sen University Guangzhou Guangdong Province China

5. Guangzhou SALIAI Stem Cell Science and Technology Co., Ltd. Guangdong Saliai Stem Cell Research Institute Guangzhou Guangdong Province China

6. Department of Endocrinology, Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou Guangdong Province China

7. Department of Neurology Mayo Clinic Rochester Minnesota USA

8. State Key Laboratory of Membrane Biology, Tsinghua‐Peking Center for Life Sciences, IDG/McGovern Institute for Brain Research, Beijing Advanced Innovation Center for Structural Biology, School of Pharmaceutical Sciences Tsinghua University Beijing China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/glia.24271

Reference58 articles.

1. Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of Edaravone